en
Scientific article
Open access
English

Mental health and its associations with glucose-lowering medication in women with gestational diabetes mellitus. A prospective clinical cohort study

Published inPsychoneuroendocrinology, vol. 124, 105095
Publication date2021-02
First online date2020-12-01
Abstract

Aims: Mental health symptoms are frequent in women with gestational diabetes mellitus (GDM) and may influence glycemic control. We therefore investigated if mental health symptoms (high depression and low well-being scores) predicted a need for glucose-lowering medication and if this use of medication influenced the trajectory of mental health during pregnancy and in the postpartum period.

Methods: We included 341 pregnant women from a cohort of GDM women in a Swiss University Hospital. The World Health Organization Well-being Index-Five was collected at the first and last GDM and at the postpartum clinical visits and the Edinburgh Postnatal Depression Scale at the first GDM and the postpartum clinical visits. Medication intake was extracted from participants' medical records. We conducted linear and logistic regressions with depression as an interaction factor.

Results: Mental health symptoms did not predict a need for medication (all p ≥ 0.29). Mental health improved over time (both p ≤ 0.001) and use of medication did not predict this change (all p ≥ 0.40). In women with symptoms of depression, medication was associated with less improvement in well-being at the postpartum clinical visit (p for interaction=0.013).

Conclusions: Mental health and glucose-lowering medication did not influence each other in an unfavourable way in this cohort of women with GDM.

eng
Keywords
  • Depression
  • Insulin
  • Metformin
  • Postpartum
  • Pregnancy
  • Well-being
  • Cohort Studies
  • Diabetes, Gestational / drug therapy
  • Female
  • Glucose
  • Humans
  • Mental Health
  • Postpartum Period
  • Pregnancy
  • Prospective Studies
Citation (ISO format)
GILBERT, Leah et al. Mental health and its associations with glucose-lowering medication in women with gestational diabetes mellitus. A prospective clinical cohort study. In: Psychoneuroendocrinology, 2021, vol. 124, p. 105095. doi: 10.1016/j.psyneuen.2020.105095
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal0306-4530
103views
27downloads

Technical informations

Creation02/21/2022 1:45:00 PM
First validation02/21/2022 1:45:00 PM
Update time03/16/2023 6:42:46 AM
Status update03/16/2023 6:42:45 AM
Last indexation02/01/2024 8:20:08 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack